Waite R P, Pang C C
Department of Pharmacology & Therapeutics, Faculty of Medicine, University of British Columbia, Vancouver, Canada.
J Pharmacol Exp Ther. 1992 Jan;260(1):45-50.
The effects of endothelin-1 (ET-1) or normal saline (0.9% NaCl) on mean arterial pressure (MAP), heart rate (HR) and mean circulatory filling pressure (MCFP), an index of body venous tone, were studied in 10 groups (n = 6 each) of conscious, unrestrained rats continuously i.v. infused with vehicle, verapamil, both hexamethonium and verapamil, phentolamine or, both phentolamine and verapamil. Infusion (i.v.) of normal saline into the five control groups did not significantly alter MAP, HR or MCFP. Cumulative i.v. bolus of ET-1 (0.8, 1.6, 3.2, 6.4, 12.8 and 19.4 x 10(-10) mol/kg) reduced HR in all five treatment groups and dose-dependently increased MAP in the presence of either vehicle or phentolamine, but did not affect MAP in the groups treated with verapamil. The ability of ET-1 to reduce HR in verapamil-treated rats, despite the absence of a pressor response, suggests that ET-1 is negatively chronotropic. ET-1 alone slightly increased MCFP and it did not alter MCFP in the presence of phentolamine. In the presence of verapamil, ET-1 markedly raised MCFP, and this was abolished by concurrent treatment with either hexamethonium or phentolamine. Therefore, ET-1 markedly elevates venous tone in the presence of verapamil via reflex-mediated increase in sympathetic nerve activity and the activation of alpha adrenoceptors.
在10组(每组n = 6)清醒、未束缚的大鼠中,持续静脉内输注溶媒、维拉帕米、六甲铵和维拉帕米、酚妥拉明或酚妥拉明与维拉帕米,研究内皮素-1(ET-1)或生理盐水(0.9% NaCl)对平均动脉压(MAP)、心率(HR)和平均循环充盈压(MCFP,身体静脉张力指标)的影响。向五个对照组静脉内输注生理盐水不会显著改变MAP、HR或MCFP。累积静脉推注ET-1(0.8、1.6、3.2、6.4、12.8和19.4×10⁻¹⁰mol/kg)在所有五个治疗组中均降低HR,并且在存在溶媒或酚妥拉明的情况下剂量依赖性增加MAP,但在用维拉帕米治疗的组中不影响MAP。尽管没有升压反应,但ET-1在维拉帕米治疗的大鼠中降低HR的能力表明ET-1具有负性变时作用。单独使用ET-1会轻微增加MCFP,并且在存在酚妥拉明的情况下不会改变MCFP。在存在维拉帕米的情况下,ET-1显著升高MCFP,并且通过同时用六甲铵或酚妥拉明治疗可消除这种升高。因此,在存在维拉帕米的情况下,ET-1通过反射介导的交感神经活动增加和α肾上腺素能受体的激活显著提高静脉张力。